2014
DOI: 10.1016/j.bmcl.2014.05.088
|View full text |Cite
|
Sign up to set email alerts
|

2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site

Abstract: 2-Aminobenzoxazoles have been synthesized as ligands for the hepatitis C virus (HCV) internal ribosome entry site (IRES) RNA. The compounds were designed to explore the less basic benzoxazole system as a replacement for the core scaffold in previously discovered benzimidazole viral translation inhibitors. Structure-activity relationships in the target binding of substituted benzoxazole ligands were investigated.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
41
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 31 publications
(41 citation statements)
references
References 18 publications
(20 reference statements)
0
41
0
Order By: Relevance
“…4F, translocation of the HCV subdomain IIa RNA construct is sterically hindered when using a ~3 nm diameter nanopore, while passage of the construct after it adopts its drug-induced linear conformation is largely unhindered. To sense this conformational shift, nanopore experiments were conducted with the RNA construct in its natively bent conformation, as well in the presence of two benzimidazole derived drugs that bind with different affinities ( 1 : K d = 3.4 μM, 2 : K d = 64 μM, measured by an independent FRET assay 42,44 ). Dwell-time histograms in the presence of different drug concentrations are shown in Fig.…”
Section: Point-of-care Applicationsmentioning
confidence: 99%
“…4F, translocation of the HCV subdomain IIa RNA construct is sterically hindered when using a ~3 nm diameter nanopore, while passage of the construct after it adopts its drug-induced linear conformation is largely unhindered. To sense this conformational shift, nanopore experiments were conducted with the RNA construct in its natively bent conformation, as well in the presence of two benzimidazole derived drugs that bind with different affinities ( 1 : K d = 3.4 μM, 2 : K d = 64 μM, measured by an independent FRET assay 42,44 ). Dwell-time histograms in the presence of different drug concentrations are shown in Fig.…”
Section: Point-of-care Applicationsmentioning
confidence: 99%
“…5 Two drugs were used in this study, as shown in Figure 2a: positive control drug 1 has been shown using FRET to bind to the elbow region of the IRES domain with a dissociation constant of ~3 μ M, 5 while negative control 2 is an analogue drug with a much weaker affinity of ~64 μ M. 26 Therefore, in this study compound 1 serves as a positive control and compound 2 as a negative control. Binding and conformational change induced by compound 1 to the HCV RNA was confirmed by repeating the FRET assay performed by Parsons and co-workers (Figure 2b).…”
mentioning
confidence: 99%
“…The IRES subdomain IIa switch has been exploited as a therapeutic target to selectively suppress viral translation with synthetic inhibitors that capture specific conformations of the RNA (5,7,(9)(10)(11)(12). High levels of conservation in HCV clinical isolates and the presence of a deep solvent-excluded ligand binding pocket render the IIa RNA switch a target for the development of antiviral drugs.…”
Section: Significance and Applications Of The Iia Switchesmentioning
confidence: 99%